guest ::
| Home > Publications Database > The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s disease. > print |
| Home > Publications Database > The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s disease. > print |
| 001 | 157821 | ||
| 005 | 20240722121853.0 | ||
| 024 | 7 | _ | |a 10.1111/ene.14733 |2 doi |
| 024 | 7 | _ | |a pmid:33449400 |2 pmid |
| 024 | 7 | _ | |a 1351-5101 |2 ISSN |
| 024 | 7 | _ | |a 1468-1331 |2 ISSN |
| 024 | 7 | _ | |a 1471-0552 |2 ISSN |
| 024 | 7 | _ | |a altmetric:97849728 |2 altmetric |
| 037 | _ | _ | |a DZNE-2021-01278 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Zimmermann, Milan |0 P:(DE-2719)9000951 |b 0 |e First author |u dzne |
| 245 | _ | _ | |a The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s disease. |
| 260 | _ | _ | |a Oxford |c 2021 |b Blackwell Science |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1721640406_12032 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a ISSN 1468-1331 not unique: **2 hits**. |
| 520 | _ | _ | |a Parkinson´s disease (PD) has a large phenotypic variability, which may, at least partly, be genetically driven including alterations of gene products. Candidates might not only be proteins associated with disease risk but also pathways that play a role in aging.To evaluate phenotype-modifying effects of genetic variants in Klotho, a longevity gene.We analyzed two longitudinal cohorts: one local cohort comprising 459 PD patients who underwent genotyping for the KL-VS haplotype in Klotho including a subgroup of 125 PD patients and 50 healthy controls who underwent biochemical cerebrospinal fluid (CSF) analyses of Klotho and fibroblast growth factor 23 as well as vitamin D metabolites. The second cohort comprised 297 patients from the Parkinson's Progression Markers Initiative (PPMI) for validation of genetic-clinical findings.PD patients carrying the KL-VS haplotype demonstrated a shorter interval between PD onset and onset of cognitive impairment (both cohorts) and higher Unified Parkinson´s Disease Rating Scale part III (UPDRS III) scores (PPMI). CSF protein levels of Klotho and fibroblast growth factor 23 were lower in PD patients irrespective of gender compared to controls. Moreover, low CSF levels of Klotho were associated with higher scores in the UPDRS III and Hoehn and Yahr Scale.Our results indicate that genetic variants in Klotho together with its corresponding CSF protein profiles are associated with aspects of disease severity in PD. These findings suggest that pathways associated with aging might be targets for future biomarker research in PD. |
| 536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 0 |
| 542 | _ | _ | |i 2021-02-06 |2 Crossref |u http://creativecommons.org/licenses/by-nc/4.0/ |
| 542 | _ | _ | |i 2021-02-06 |2 Crossref |u http://doi.wiley.com/10.1002/tdm_license_1.1 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a Klotho |2 Other |
| 650 | _ | 7 | |a Parkinson´s disease |2 Other |
| 650 | _ | 7 | |a aging |2 Other |
| 650 | _ | 7 | |a genetic modifier |2 Other |
| 650 | _ | 7 | |a longevity genes |2 Other |
| 650 | _ | 7 | |a Biomarkers |2 NLM Chemicals |
| 650 | _ | 7 | |a Cerebrospinal Fluid Proteins |2 NLM Chemicals |
| 650 | _ | 2 | |a Biomarkers |2 MeSH |
| 650 | _ | 2 | |a Cerebrospinal Fluid Proteins |2 MeSH |
| 650 | _ | 2 | |a Cohort Studies |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Longevity |2 MeSH |
| 650 | _ | 2 | |a Mental Status and Dementia Tests |2 MeSH |
| 650 | _ | 2 | |a Parkinson Disease: genetics |2 MeSH |
| 700 | 1 | _ | |a Köhler, Leonie |b 1 |
| 700 | 1 | _ | |a Kovarova, Marketa |b 2 |
| 700 | 1 | _ | |a Lerche, Stefanie |0 P:(DE-2719)2812186 |b 3 |u dzne |
| 700 | 1 | _ | |a Schulte, Claudia |0 P:(DE-2719)9000366 |b 4 |u dzne |
| 700 | 1 | _ | |a Wurster, Isabel |0 P:(DE-2719)2812736 |b 5 |u dzne |
| 700 | 1 | _ | |a Machetanz, Gerrit |0 P:(DE-2719)9000193 |b 6 |u dzne |
| 700 | 1 | _ | |a Deuschle, Christian |0 P:(DE-2719)2812432 |b 7 |u dzne |
| 700 | 1 | _ | |a Hauser, Ann-Kathrin |0 P:(DE-2719)2351249 |b 8 |u dzne |
| 700 | 1 | _ | |a Gasser, Thomas |0 P:(DE-2719)2320009 |b 9 |u dzne |
| 700 | 1 | _ | |a Berg, Daniela |0 P:(DE-2719)2000059 |b 10 |u dzne |
| 700 | 1 | _ | |a Schleicher, Erwin |b 11 |
| 700 | 1 | _ | |a Maetzler, Walter |0 P:(DE-2719)2810915 |b 12 |u dzne |
| 700 | 1 | _ | |a Brockmann, Kathrin |0 P:(DE-2719)2811916 |b 13 |e Last author |u dzne |
| 773 | 1 | 8 | |a 10.1111/ene.14733 |b Wiley |d 2021-02-06 |n 5 |p 1557-1565 |3 journal-article |2 Crossref |t European Journal of Neurology |v 28 |y 2021 |x 1351-5101 |
| 773 | _ | _ | |a 10.1111/ene.14733 |g Vol. 28, no. 5, p. 1557 - 1565 |0 PERI:(DE-600)2020241-6 |n 5 |p 1557-1565 |t European journal of neurology |v 28 |y 2021 |x 1351-5101 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/157821/files/DZNE-2021-01278.pdf |y OpenAccess |
| 856 | 4 | _ | |u https://pub.dzne.de/record/157821/files/DZNE-2021-01278.pdf?subformat=pdfa |x pdfa |y OpenAccess |
| 909 | C | O | |o oai:pub.dzne.de:157821 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)9000951 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)2812186 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 4 |6 P:(DE-2719)9000366 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 5 |6 P:(DE-2719)2812736 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 6 |6 P:(DE-2719)9000193 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 7 |6 P:(DE-2719)2812432 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 8 |6 P:(DE-2719)2351249 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 9 |6 P:(DE-2719)2320009 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 10 |6 P:(DE-2719)2000059 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 12 |6 P:(DE-2719)2810915 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 13 |6 P:(DE-2719)2811916 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 914 | 1 | _ | |y 2021 |
| 915 | _ | _ | |a Creative Commons Attribution-NonCommercial CC BY-NC 4.0 |0 LIC:(DE-HGF)CCBYNC4 |2 HGFVOC |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EUR J NEUROL : 2021 |d 2022-11-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2022-11-11 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2022-11-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2022-11-11 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b EUR J NEUROL : 2021 |d 2022-11-11 |
| 920 | 1 | _ | |0 I:(DE-2719)1210000 |k AG Gasser |l Parkinson Genetics |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1240005 |k Core ICRU |l Core ICRU |x 1 |
| 920 | 1 | _ | |0 I:(DE-2719)5000055 |k AG Berg |l Parkinson's Disease Genetics |x 2 |
| 920 | 1 | _ | |0 I:(DE-2719)1240004 |k Biobanking Facility Tübingen |l Biobanking Facility Tübingen |x 3 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1210000 |
| 980 | _ | _ | |a I:(DE-2719)1240005 |
| 980 | _ | _ | |a I:(DE-2719)5000055 |
| 980 | _ | _ | |a I:(DE-2719)1240004 |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | 1 | _ | |a FullTexts |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1001/archneur.61.12.1906 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00401-011-0852-9 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1038/ng.3955 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1038/ng.3043 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1074/jbc.C500457200 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1038/36285 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1126/science.1112766 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.4155/fmc.12.134 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1038/nature05315 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.exger.2017.10.023 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.brainres.2011.01.056 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.3233/JPD-130230 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00424-016-1858-x |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/mds.23991 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00702-014-1276-1 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1212/WNL.0b013e318225ab77 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1136/jnnp.55.3.181 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/mds.22340 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/mds.20213 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1111/j.1532-5415.2005.53221.x |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/0022-3956(75)90026-6 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/mds.26062 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1212/WNL.0b013e3181c34b47 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1037/t00742-000 |2 Crossref |u BeckAS BrownGK.Manual for the Beck Depression Inventory‐II. San Antonio: Psychological Corporation 1996. |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.neulet.2013.10.058 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1152/ajpgi.00243.2005 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1212/WNL.0000000000007323 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.neurobiolaging.2018.12.014 |2 Crossref |
| 999 | C | 5 | |1 de Vries CF |y 2018 |2 Crossref |o de Vries CF 2018 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|